CLINICAL_TRIALS
trial_result
· 2018-08-21
Clinical Trial Update: A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas [Phase 2]
Summary
Phase II study evaluating tivozanib in patients with metastatic and non-resectable soft tissue sarcomas has completed, with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwestern University | Conditions: Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2018-08-21